Editorial: Signal Transduction Inhibitors as Promising Anticancer Agents
Santos, Cedric Dos
Ahluwalia, Tarunveer Singh
MetadataShow full item record
Cancer is a group of diseases sharing common features like unrestrictive growth, metastasis, and angiogenesis; however the basic signal transduction pathways are deregulated to such an extent that every cancer case itself poses new challenges for the therapeutics. Worldwide approximately 7.6 million people died of cancer in year 2008 and it has been projected that 13.1 million deaths will be due to cancer by year 2030. Understanding the disease etiology and dysregulation of tissue microenvironment, signal transduction pathways are the potential directions, which may help us find the possible cure for the disease. However, recent advances in cancer therapeutics are proving to be beneficial for the patients but there is still a lot to be desired. Continuous research worldwide is focusing on developing better therapeutics as well as finding novel druggable targets for better efficacy. Another recent development is novel multitarget drugs, which may increase the efficacy manyfold.